Related Experiment Video
Updated: May 5, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes
Andrea Gissi1, Domenico Gadaleta, Matteo Floris
1Dipartimento di Farmacia - Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Bari, Italy.
New quantitative structure-activity relationship (QSAR) models predict chemical bioconcentration factors (BCF), offering a reliable alternative to animal testing for regulatory compliance under REACH and BPR. These models reduce costs and ethical concerns associated with traditional methods.
Area of Science:
- Environmental Chemistry
- Toxicology
- Computational Chemistry
Background:
- REACH and BPR regulations encourage non-animal testing for chemical risk assessment.
- Quantitative Structure-Activity Relationship (QSAR) models are gaining importance as alternatives to animal testing.
- Assessing Bioconcentration Factor (BCF) is crucial for regulatory compliance but is costly and time-consuming using traditional methods.
Purpose of the Study:
- To develop and validate QSAR models for predicting chemical Bioconcentration Factor (BCF).
- To provide a reliable, cost-effective, and ethical alternative to in vivo animal testing for BCF assessment.
- To support regulatory compliance under REACH and BPR frameworks.
Main Methods:
- Development of QSAR models using the ANTARES dataset, comprising verified experimental BCF data.
- Utilized a nine-descriptor model trained on 608 chemicals.
- Validated the model using separate validation (152 chemicals) and blind (76 chemicals) datasets.
- Implemented multi-step applicability domain assessment and safety margins for robustness.
Main Results:
- A highly predictive nine-descriptor QSAR model was developed.
- The model demonstrated satisfactory predictive power on external and blind datasets.
- The model's robustness was confirmed through rigorous validation strategies.
- The use of meaningful biokinetics descriptors ensures model interpretability.
Conclusions:
- The developed QSAR models offer a reliable alternative to in vivo BCF assays.
- These models can assist registrants in meeting regulatory requirements efficiently and ethically.
- The study supports the reduction of animal testing in chemical risk assessment.
More Related Videos
08:00Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
Published on: December 4, 2016
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Dosage Regimens: Partial Pharmacokinetic Parameters
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pharmacodynamic Models: Linear Concentration–Effect Model
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Measurement of Bioavailability: Pharmacodynamic Methods